You are here
- Home
- tertiary healthcare
tertiary healthcare
- What is CAR T-cell therapy?Kayleigh KewDrug and Therapeutics Bulletin May 2021, 59 (5) 73-76; DOI: 10.1136/dtb.2020.000040
- CLINICAL
- Anaesthesia (24)
- Cardiovascular Medicine (225)
- Dermatology (72)
- Diagnostics (11)
- Drugs and medicines
- Cardiovascular system (152)
- Drug interactions (12)
- Ear, nose and throat (57)
- Endocrine system (115)
- Eye (24)
- Infections (215)
- Nutrition (94)
- Renal system (12)
- Respiratory system (119)
- Skin (26)
- Emergency medicine (22)
- Endocrinology (103)
- Gastroenterology (97)
- Genetics (20)
- Infectious diseases (126)
- Neurology (203)
- Oncology (98)
- Ophthalmology (24)
- Paediatrics (88)
- Palliative care (5)
- Pathology (3)
- Pharmacology and therapeutics
- Clinical trials (7)
- Drug interactions (12)
- Efficacy (7)
- Formulation (2)
- Medicines regulation (22)
- Pharmacokinetics (1)
- Safety (27)
- Toxicology (17)
- Psychiatry (111)
- Radiology (13)
- Renal medicine (23)
- Respiratory medicine (130)
- Rheumatology (81)
- Sexual Health (49)
- Surgery (3)
- Urology (43)
- NON-CLINICAL
- Epidemiology (116)
- Ethics (16)
- Health economics (13)
- Health Policy (21)
- Journalology (3)
- Medical Management (12)
- Patients (23)
- Public health (274)
- Smoking and tobacco (15)
- Special Collections
- DTB Education (105)
- DTB Select (131)